CleanSlate Stock

cleanslatecenters.comHealthcare / Other HealthcareFounded: 1900Funding to Date: $79.02MM

CleanSlate is a national medical group that provides treatment for the chronic disease of addiction using an integrated approach combining medication-assisted treatment, primary care services and behavioral health therapies to treat polysubstance use disorder and associated co-occurring disorders.

Register To Buy and Sell Shares

For more details on financing and valuation for CleanSlate, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access CleanSlate’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like CleanSlate.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Anthony Belott
Chief Development Officer
Paul Chabot
Chief Information Officer
Robert Hutchison
Chief Financial Officer
Gregory Marotta
President, Board Member & Chief Executive Officer
Bob Wilson
Chief Human Resources Officer
Amanda Wilson MD
Founder & Chairwoman
Adam McPhee
Chief Operating Officer
Neil Kunkel JD
Chief Legal Officer
Tracey Cohen MD
Chief Clinical Officer

Board Members

Christopher Jedrey Ph.D
Jared Teo
HealthQuest Capital
Paul Brown JD
Eugene Fleming
Garheng Kong MD
HealthQuest Capital
Patrick Kennedy
Diane Daych
Granite Growth Health Partners
Mark Brooks
Granite Growth Health Partners
Amanda Wilson MD

Frequently Asked Questions About CleanSlate’s Stock

Can you buy CleanSlate’s stock?
CleanSlate is not publicly traded on NYSE or NASDAQ in the U.S. To buy CleanSlate’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.
Can you sell CleanSlate’s stock?
Yes, you can sell stock of a private company like CleanSlate. Forge can help you sell your CleanSlate stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.
What is CleanSlate’s stock price?
CleanSlate is a privately held company and therefore does not have a public stock price. However, you may access CleanSlate’s private market stock price with Forge Data.
What is CleanSlate’s stock ticker symbol?
CleanSlate does not have an official ticker symbol because this company is not currently publicly traded.
Can institutional investors buy and sell private market stocks?
Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

News Highlights

AG: CleanSlate treatment centers and former owner billed MassHealth for unneeded tests - The Boston Globe
A substance abuse treatment company and its former owner, Dr. Amanda L. Wilson, wrongly charged MassHealth millions of dollars for urine tests patients did not need, Attorney General Maura Healey alleges in a new federal lawsuit.
CleanSlate UV Raises $7M in Series A Financing | FinSMEs
CleanSlate UV, a Toronto, Canada and Buffalo, NY-based infection control startup offering a hospital-grade, chemical-free sanitizer for mobile devices, raised US$7m in initial close of a new financing round
CleanSlate Announces $25 Million Funding to Expand Opioid and Alcohol Addiction Treatment across the Nation
National leader in outpatient pharmacological treatment for the chronic disease of addiction announces $25 million in financing to accelerate growth.
Updated on: Apr 19, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.